American Heart Journal
Volume 156, Issue 2 , Page 255, August 2008

Correction

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-8703(08)00479-1

doi:10.1016/j.ahj.2008.06.012

Refers to article:

  • Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10) , 21 January 2008

    Robert Wilcox, Stuart Kupfer, Erland Erdmann, on behalf of the PROactive Study investigators
    American Heart Journal April 2008 (Vol. 155, Issue 4, Pages 712-717)

American Heart Journal
Volume 156, Issue 2 , Page 255, August 2008

Article Tools